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The  investigation  of microbial  infections  relies  to a large  part  on animal  models  of  infection,  if host
pathogen  interactions  or  the  host  response  are considered.  Especially  for  the assessment  of  novel  ther-
apeutic  agents,  animal  models  are required.  Non-invasive  imaging  methods  to study  such  models  have
gained  increasing  importance  over  the  recent  years.  In  particular,  magnetic  resonance  imaging  (MRI)vailable online 7 November 2013
eywords:
icrobial infections
RI  modalities
affords  a variety  of diagnostic  options,  and  can be  used  for longitudinal  studies.  In  this review,  we intro-
duce  the  most  important  MRI  modalities  that show  how  MRI  has  been  used  for the investigation  of  animal
models  of infection  previously  and  how  it may  be applied  in  the  future.
©  2013  The  Authors.  Published  by  Elsevier  B.V. Open access under CC BY-NC-ND license.olecular imaging
ontrast agents
. Introduction
Magnetic resonance imaging (MRI) has developed into the most
ersatile and widely used clinical diagnostic tool over the last three
ecades. MRI  is an essential part of the clinical diagnostic rou-
ine in acute injury, musculoskeletal disease, pathologies of the
rain such as stroke or neurodegenerative disease, detection and
taging of cancer, and in cardiac imaging. However, for the diagno-
is of infectious disease, both bacterial and viral, its application is
imited and it is primarily used to detect local inﬂammation, edema
ormation and other manifestations of the immune response, but
ot to detect the infectious agent directly or follow the spread of
etastatic infections [1–3]. This lack of application is astonishing,
ince infectious disease is still one of the major unsolved problems
n health care worldwide.
Research in medical microbiology consists of two  main ﬁelds
f inquiry. The ﬁrst investigates the pathology and host interac-
ions important to understand the mechanisms of the disease and
evelop novel therapeutic strategies. Second resistance mecha-
isms have to be explored and novel agents tested. In addition
o basic scientiﬁc investigation research is also prompted by the
rgent clinical need for more speciﬁc and efﬁcient diagnostic tools
or infectious diseases. Many infections can lead to severe diseases
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Open access under CC BY-NC-ND lisuch as endocarditis, osteomyelitis, or encephalopathies, which
often result in devastating conditions. In particular, early or chronic
infections are difﬁcult to detect and, for example in osteomyelitis,
it is often not possible to distinguish non-infected from infected tis-
sue intra-operatively. A diagnostic imaging tool that non-invasively
detects pathogens and discriminates between bacterial infections
and other sources of inﬂammation would greatly enhance diag-
nostic and therapeutic options and thus aid disease management.
To this end different imaging techniques such as bioluminescence
(BLI) and ﬂuorescence imaging, positron emission tomography
(PET), single photon emission computed tomography (SPECT) and
MRI  have been developed and applied to both patients and animal
models of infections [1,3–5].
PET methods usually detect the dissemination of pathogens
indirectly via changes in cellular processes and metabolic turn over.
With SPECT a number of promising speciﬁc radiotracer molecules
based on antibiotics, antimicrobial peptides, cytokines, or mono-
clonal antibodies have been suggested to speciﬁcally label bacterial
infections. However, due to the low resolution of this technique
further and improved imaging modalities are required [6]. For pre-
clinical or basic microbiological research purposes BLI, ﬂuorescence
imaging (ﬂuorescence reﬂectance imaging (FRI)) and ﬂuorescence
mediated tomography (FMT) represent promising alternative tech-
nologies [4,7]. BLI studies of viral or bacterial infections are typically
performed using recombinant pathogens, genetically engineered to
express a luciferase enzyme. Low sensitivity of a single bacterium,
however, limits the application of BLI. By contrast, ﬂuorescence
imaging using green or red ﬂuorescent proteins allows in vivo
detection of single cells when invasive methods are applied. When
used for non-invasive imaging, however, autoﬂuorescence and
scattering become signiﬁcantly limiting issues. To this end, near-
infrared ﬂuorescent probes have been developed, which possess
cense.
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reat potential for this purpose, since red ﬂuorescent dyes increase
enetration depth and reduce problems caused by green auto-
uorescence of tissue [8]. Recently, the feasibility of detecting
nﬂammation in the murine lung by FMT  has been shown [7]. How-
ver, due to the poor spatial resolution and the lack of intrinsic
ontrast FMT  requires co-registration with other modalities, such
s MRI.
While BLI, FMT, and also FRI are valuable tools for research
n animal models and may  contribute to our understanding of
athogenicity mechanisms of microorganisms, their application in
atients is most unlikely. Finally, pathogens have been indirectly
etected by MR  diagnostic imaging through edema formation and
hanges in local tissue parameters such as relaxation time, water
ontent, or diffusivity. Both for the development of novel imaging
echnologies and for the understanding of disease mechanisms and
mmune response the use of small animal models of infections is
mportant to simulate the complex interactions in the living organ-
sm. A general review of imaging techniques with respect to their
pplication in small animal models of infection has recently been
ublished [3]. This review will focus on current MRI  techniques and
ecent MRI  developments, which are applicable to microbiology
esearch using animal models of infection.
. Endogenous MRI  contrast
The strength of MRI  lies in its excellent intrinsic soft tissue con-
rast, unlimited penetration depth, and high anatomical resolution.
mall local differences in tissue relaxation time, water content, or
iffusivity can be detected readily by T1, T2, proton density, or dif-
usion weighted spin echo or gradient echo MR sequences, and can
ubsequently be related to deﬁned anatomical structures with high
ccuracy. Usually both spin echo and gradient echo sequences can
e used to create the desired contrast, however, gradient echoes
re preferred when susceptibility differences are expected as major
ource of contrast. These effects are most pronounced in gradient
cho images, since the detected echo is created by matching bipo-
ar gradients, which do not refocus magnetic ﬁeld inhomogeneities
9]. To some extent all of these parameters affect the contrast in the
cquired MR  image. However, by choice of the appropriate echo
imes (TE) and repetition times (TR), a particular type of contrast
an be emphasized. Table 1 lists the typical TE and TR values used
or spin echo and gradient echo sequences to achieve a speciﬁcally
eighted image [10]. Corresponding spin echo images of the mouse
rain are shown in Fig. 1A.
T1 weighted images are less sensitive to subtle differences in
oft tissue composition and may  be suitable to depict anatomical
tructures with high resolution. T2 weighted images are usu-
lly more sensitive to water content and molecular composition
f soft tissue, and therefore T2 weighting is the most common
echnique to describe and recognize pathologically altered tissue.
roton density-weighted images are mostly used to resolve the
ross anatomical structure. In infections the pathogenicity of bacte-
ia, viruses, fungi, and parasites usually originates from a single
lass or a small number of molecules such as toxins, exoenzymes,
dhesins, or immune-modulating proteins, which are released from
he pathogen. Many of these PAMPs (pathogen associated molec-
lar pattern) are recognized by members of the Toll-like receptor
TLR) trans-membrane protein family. These proteins play a key
ole in mediating the systemic responses to invading pathogens,
nd trigger automatic inﬂammation processes including dilated
lood vessels and increased blood ﬂow [11] as one of the ﬁrst
esponses to an infection [12]. The increased blood ﬂow helps
efensive immune cells such as leucocytes (macrophages, neu-
rophils, dendritic cells, mast cells, eosinophils, basophils, and
atural killer cells) and lymphocytes (B and T cells) reach thed Biomedical Analysis 93 (2014) 136–146 137
place of infection. Additionally, complement activation is often
involved in inﬂammation and leads to a high concentration of a
variety of different proteins and antibodies in the region of infec-
tion [13]. The combination of all immunological reactions leads
to a high proton density and prolonged tissue relaxation times
at the site of infection. These can be detected easily as hyperin-
tensities in T2 weighted images [14,15]. Thus, lesions in the brain
with bright MRI  signals have been detected and characterized suc-
cessfully with respect to Shiga toxin-producing Escherichia coli
infections [16], Herpes simplex encephalitis (Fig. 2) [17–19], Crypto-
coccal meningoencephalitis [20], Citrobacter koseri brain abscesses
[21], sepsis-associated encephalopathy [22], Lymphocytic Chori-
omeningitis Virus infections [23], and Toxoplasma gondii brain
infections [24]. Recently, endogenous T2 contrast was also deﬁned
as early marker of cerebral malaria, one of the most severe com-
plications caused by Plasmodium falciparum.  This disease results in
damaged optical and trigeminal nerves, depicted as hypointensi-
ties in T2 weighted imaging [25–27]. In addition to animal models of
cerebral infections lesions of inﬂammation were successfully inves-
tigated by endogenous T1 and T2 contrast in Staphylococcus aureus
induced osteomyelitis [28], Helicobacter bilis-induced colon cancer
[29], LPS-induced sepsis [30], Aspergillus fumigates,  Candida albicans
and S. aureus-induced muscle infections [31–33] as well as in Strep-
tococcus or Klebsiella-induced pneumonia [34,35], and pulmonary
alveolar Echinococcosis [36].
Proton MRI  of the lung is known to be especially challenging
since air-tissue interfaces produce strong susceptibility artifacts
leading to very fast T2* relaxation. In the work of Marzola et al.
it was shown that edema formation in lung infections resulted in
signiﬁcantly modiﬁed lung tissue, leading to a signiﬁcant increase
in T2* which allowed for the detection of hyperintense lesions in
both T2* and T1 weighted gradient echo images [35]. The applica-
bility of this technique to Pseudomonas aeruginosa-induced cystic
lung ﬁbrosis [37] and poststroke pneumonia [38] were also studied.
Recent developments are based on the application of hyperpolar-
ized 3He and 129Xe gases to assess the lung function during an
infection [39].
The excellent soft tissue contrast of MRI can also detect abnor-
malities of the gastrointestinal tract [40,41]. Recent studies focused
on the spleen, which is the most important organ in ﬁltering infec-
tious microorganisms. Structural and functional changes of the
spleen in a Plasmodium infection were analyzed using T2 maps and
T1 weighted steady-state imaging [42].
Besides the strong tissue contrast induced by differences in the
relaxation times, changes in the self-diffusion of water molecules
can be used as a parameter to detect and characterize zones of
inﬂammation. Molecular diffusion is usually a three-dimensional
motion and free water diffuses randomly in all spatial directions.
In tissue, however, random Brownian motion of water molecules
is restricted by surrounding tissue, leading to preferred water
diffusion along the orientation of neuronal or muscular ﬁbers.
The diffusion anisotropy represents a reasonable measure of the
anisotropy of tissue structure. The diffusivity of water molecules
is usually measured as the apparent diffusion coefﬁcient (ADC)
and the preferred diffusion directions are characterized by the
fractional anisotropy (FA). Both parameters are usually measured
three-dimensionally using DTI with diffusion encoding along 30
or more directions (Fig. 1B) [43,44]. Thus, the local diffusion
anisotropy and diffusion coefﬁcient can be calculated and modeled
by a tensor, providing data of diffusion directions in the tissue of
interest. When tissue is inﬂamed or destroyed by injuries, the cell
density is diminished due to large amounts of inﬁltrating water
or cell swelling. The result is dramatic changes in water diffu-
sivity and the resulting tissue ADC and FA values [45,46]. This
approach has been applied to the study of the development and
progression of pneumococcal meningitis [47,48], sepsis-associated
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Fig. 1. Classical MRI  modalities. (A) Coronal turbo spin echo (RARE) images of the mouse brain showing proton density-, T2- and T1-weighted MR contrast. (AI) proton density
(TE:  9.8 ms,  TR: 3000 ms), (AII) T2 (TE: 69 ms,  TR: 3000 ms)  and (AIII) T1 (TE: 9.8 ms,  TR: 400 ms)  weighted images were acquired at 9.4 T with the following parameters (slice
thickness: 1 mm,  ﬁeld of view: 2 cm × 2 cm, matrix size: 206 × 206, number of averages: 4). (B) Coronal diffusion tensor imaging (DTI) of the mouse brain showing (BI) the
fractional anisotropy (FA), (BII) preferred diffusion directions encoded by the indicated color sphere, and (BIII) the local apparent diffusion coefﬁcient (ADC), depicted as
ADC  map. High ADC values appear bright on the map  and indicate less tightly organized tissue. Images were acquired at 9.4 T with the following parameters (TE: 35 ms, TR:
2250  ms,  slice thickness: 1 mm,  30 gradient directions, B value 1000 s/mm2, ﬁeld of view: 2 cm × 2 cm,  matrix size: 128 × 128).
Fig. 2. Cerebral inﬂammation induced by Herpes simplex virus-1. Coronal T2 weighted turbo spin echo (RARE) images of the mouse brain. (A) Brain of a healthy mouse.
(B)  Day 7 of an herpes simplex virus-1 infected mouse showing expanded lesions from the Bulbus olfactorius to the Cortex cerebri (yellow arrows in the lateral areas of the
brain).  Images were acquired on a 9.4 T Biospec 94/20 small animal scanner with the following parameters (TE: 40 ms, TR: 4500 ms,  slice thickness: 0.6 mm,  ﬁeld of view:
2  cm × 2 cm, matrix size: 256 × 256, number of averages: 4). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of
this  article.)
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Table  1
Typical TE and TR values used for spin echo and gradient echo sequences.
Imaging technique Repetion time, TR [ms]d Echo time, TE [ms]d
Spin echo Gradient echo Spin echo Gradient echo
T1 weighteninga 250–500 <50e ≤10 <3
T2 weighteningb ≥3000 >100e >50–100 >5
Proton-density weighteningc ≥3000 >100e ≤10 <3
a Requires both short TR and short TE.
b Requires both long TR and long TE.
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e TR depends on the applied ﬂip angle.
ncephalopathy [22] and maternal infection-induced white and
ray matter injuries [45]. Different protective compounds were
ssessed according to their cerebral injury outcome during mater-
al inﬂammation [45].
Finally, DTI and T2 contrast provide complementary informa-
ion, which can be used for making a differential diagnosis. By
ombining the information obtained from DTI and T2 weighted
maging, changes in the water content in the brain have been
elated to different forms of brain edema [49]. While vasogenic
dema showed changes in the T2 relaxation time [50,51], the ADC
alue of water seemed to be more sensitive to cytotoxic edema [52].
ecently, this differentiation was used to study the cause of early
rain edema formation in an LPS-induced endotoxic shock mouse
odel and conclude the edema was related to microcirculatory
ailure [49].
. Functional parameterization
A second important ability of MRI  is to provide functional infor-
ation about organ impairment and failure during the course of an
nfection. Chagas disease, caused by the parasite Trypanosoma cruzi,
or example, results in severe cardiac manifestations, including
ardiomyopathy, congestive heart failure, arrhythmia and car-
ioembolism. These impairments can be evaluated structurally
nd functionally, when cardiac gated MRI  techniques are applied
41,53–62].
Due to the high heart rate of small animals, cardiac MRI  in mice
s extremely challenging and requires appropriate gating strate-
ies. Electrocardiogram (ECG) and respiratory-gated fast gradient
cho sequences are commonly applied to acquire several time
rames per cardiac cycle. However, the ECG signal often suffers
rom artifacts in fast switching gradients. As an alternative, self-
ated acquisition and retrospective reconstruction strategies have
een developed. These sequences record additional navigator data
t some point during the repetition time and retrospectively assign
he acquired data to a speciﬁc cardiac frame [63–67]. Using a stack
f 7–9 time-resolved short-axes images, the entire volume of the
yocardium and the left and right ventricle can be determined
ver the heart cycle. Detailed information about ejection fraction,
ardiac output, stroke volume and myocardial mass can then be
alculated [62]. Applications of this technique include several car-
iac MRI  studies where the right ventricular internal volume was
easured and used as a biomarker to study different aspects of
hronic chagasic pathogenesis and the therapeutic outcome under
erapamil treatment [55,68]. In another study, functional cardiac
RI  was successfully applied to assess the cardiac function of sep-
ic mice. Sick animals showed signiﬁcantly reduced cardiac output
nd stroke volumes compared to controls [62].In many infectious diseases vascular structures are involved
nd vascular function is impaired by the inﬂammatory pro-
ess. By MR  angiography (MRA) both veins and arteries can be
epicted with high resolution. In MRI, there are two main methods.
to observe the vascular structures, contrast-enhanced and non-
contrast-enhanced MRA. Contrast-enhanced MRA  detects a bolus of
an intravenous gadolinium injection using a T1 weighted sequence.
Signal is only obtained from the intravascular space, where the
contrast agent shortens T1. Non-contrast-enhanced MRA  exploits
effects of vascular ﬂow on position or phase of blood, by using meth-
ods such as time-of-ﬂight (TOF), phase-contrast MRA, ECG-gated
Turbo spin echo, steady-state free precession, or arterial spin label-
ing [69,70]. TOF and phase-contrast MRA  are the most commonly
used and robust methods, which further allow for measurement
of ﬂow velocities. While phase-contrast MRA  is frequently used
for ﬂow measurements, TOF is preferred for morphological evalu-
ation. Recent investigations of cerebral malaria in a mouse model
showed regions of ischemic brain damage and vascular blood ﬂow
perturbations [26,27,71–73]. Also recently a Porphromonas gingi-
valis infection model showed blood ﬂow was  signiﬁcantly disturbed
due to enhanced inﬂammatory artherosclerosis [74].
4. Molecular MR  imaging
Endogenous contrast of edema depends on the relaxation times
and proton density of the infected tissue, and may be difﬁcult to
detect by T1 or T2 weighted imaging. To induce signiﬁcant tissue
contrast at the site of infection, molecular imaging techniques are
increasingly applied in studies of infectious disease [75,76]. Recent
and exciting successes in the development of iron oxide parti-
cles, lanthanide chelates and ﬂuorinated compounds have allowed
researchers to speciﬁcally label immune cells and receptors at the
site of infection [77–82]. Using these targeted contrast agents the
study of host–response mechanisms and the progression and sever-
ity of inﬂammation becomes possible.
In general, cell tracking can be performed using two  different
techniques. Immune cells can be recovered from the living organ-
ism, labeled in vitro and subsequently regrafted [83]. Alternatively,
iron oxide particles can be delivered intravenously, and are then
taken up by phagocytotic cells unspeciﬁcally. More sophisticated
techniques target these particles to speciﬁc molecular structures
for example with the use of antibodies, which recognize speciﬁc
receptor molecules on the cell surface [80–82].
5. Iron oxide particles
Most frequently phagocytotic dendritic cells such as
macrophages are labeled by using superparamagnetic iron
oxide (SPIO) particles. SPIOs are available in a variety of dif-
ferent sizes and coatings. They typically consist of a crystalline
maghemite (Fe2O3) or magnetite (Fe3O4) iron core surrounded by
a polymeric shell [84]. From the smallest particles (VSOP), which
are around 7 nm in diameter, to the largest particles (MPIO), which
can achieve up to 5 m in diameter, all varieties of SPIOs have
successfully been used to label different immune, stem, or tumor
cells [85]. This technique is very sensitive and a small number or
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ven single mammalian cell can be detected and tracked by MRI
sing micron sized particles [86]. In a magnetic ﬁeld, the crystalline
tructure of the particles provides a strong resultant magnetic
oment and a large magnetic susceptibility. These effects lead
o local distortions of the magnetic ﬁeld in the scanner and thus
o shortened relaxation times. The transverse relaxation time is
ubstantially reduced, and can be detected as pronounced negative
ontrast in T2* weighted gradient echo images.
A fundamental drawback of the T2* detection of SPIOs is that
he corresponding negative contrast is sometimes difﬁcult to dis-
inguish from signal voids originating from other sources, such
s ﬁeld inhomogenities or susceptibility induced artifacts at tis-
ue interfaces. Depending on the native relaxivity of the infected
rgan and tissue, the T2* effect of iron oxide particles might become
egligible. For example strong susceptibility differences in lung tis-
ue between lung parenchyma and alveolar spaces overshadow the
looming effect of the iron. This problem has led to the develop-
ent of positive contrast MR  techniques. A hyperintense signal
iving rise to a positive contrast can be generated by exploiting dif-
erent physical properties of local dipole ﬁelds that originate from
he particles. GRASP (gradient echo acquisition for superparamag-
etic particles) sequences [87] make use of local ﬁeld gradients [88],
riginally called the white marker phenomenon [89]. FLAPS (fast
ow angle positive-contrast steady-state free precession imaging)
90] or IRON (inversion-recovery with ON-resonant water sup-
ression) [91] sequences exploit off-resonances [92,93] by either
elective excitation or saturation. For tissue with very short T2*,
ltra-short echo time (UTE) sequences have been developed that
reate positive contrast by subtraction of images acquired at dif-
erent TE [94] or by exploiting T1 effects of iron oxides [95]. Other
ore complicated approaches use non-linear spin echos [96] or
ost processing methods [97]. However, although positive contrast
equences yield images with a low background signal, local dipole
elds from any other source are also translated into positive con-
rast. Thus, while the conspicuity of labeled targets is increased, the
roblem of ambiguity is not fully resolved.
The application of SPIOs includes the study of macrophages
nd granulocytes homing in on the site of infection. Studies used
ither iron oxide-labeled immune cells or the intravenous applica-
ion of SPIOs that were phagocytosed by dentric cells. The labeled
ells appeared as holosphere around the zone of inﬂammation
Fig. 3A) [98–104], indicating the suitability of iron contrast as
iagnostic tool to detect zones of microbial infections. Another
merging application is the use of iron oxide particles to investigate
mmunological and physiological pathways. Lee et al. investigated
he interactions between invading pathogens and innate immune
gents such as chemokine, monocyte chemoattractant protein-
 and macrophage-colony-stimulating factor. In a mouse model
f S. aureus-induced muscle abscess iron labeled macrophages
ere tracked by T2*-weighted MRI  [105]. The effect of the anti-
nﬂammatory therapeutic agent CCR2, a receptor antagonist for
onocyte chemoattractant protein-1, on macrophage migration
as been studied by the same group [106]. While commonly per-
ormed T2* weighted imaging provide high special resolution,
recise localization and quantiﬁcation remain difﬁcult. Recently,
 novel and speciﬁc iron oxide probe was designed to visualize
nd quantify acute inﬂammation as an indicator of sepsis progres-
ion. To this end quantitative susceptibility mapping approaches
ere applied [107,108] to an LPS-induced sepsis model. By the
se of superparamagnetic iron oxide-based nanomicelles regions
f inﬂammation-induced over-expression of the intracellular adhe-
ion molecule-1 (ICAM-1) were identiﬁed and quantiﬁed.While notable successes have been obtained using SPIOs for
olecular imaging, this technique is frequently limited by the lack
f speciﬁcity of SPIOs. Ongoing work to create speciﬁc molecu-
ar imaging probes includes using SPIOs conjugated with IgG tod Biomedical Analysis 93 (2014) 136–146
promote cellular uptake by monocytes, and particles coated with
Mtb  surface antibody for the speciﬁc detection of extrapulmonary
mycobacterial infection [109,110]. However, since the antibody-
coated SPIOs were administered systemically, all these methods
were unable to clearly distinguish actual infection from sterile
inﬂammation. Recently, we  have reported a method to label, detect
and track bacteria directly by MRI. Stable labeling with iron-oxide
nano particles was achieved by manipulating the bacterial sur-
face charge. Production of electro-competent cells enabled charge
interactions between the particles and the cell wall. In both a subcu-
taneous and a systemic S. aureus infection model high resolution T2
and T2* weighted images allowed for bacterial tracking, in addition
to providing information on infection morphology and the inﬂam-
matory response (Fig. 3B) [111]. Alternative labeling strategies have
been reported and successfully applied for E. coli [112,113].
6. Lanthanide chelates
Lanthanide chelate complexes are common positive contrast
agents in molecular MRI  that shorten T1 relaxation time sig-
niﬁcantly, leading to strong signal enhancement in T1 weighted
images. Especially Gadolinium (Gd3+) complexes are widely used
because of their favorable physicochemical properties [114–120].
Seven unpaired electrons give Gd3+ a large magnetic moment.
Dipole-dipole interactions with the surrounding water protons
lead to efﬁcient paramagnetic relaxation enhancement. In addi-
tion, Gd3+ ions have the ability to form stable non-toxic linear and
macrocyclic complexes with eight or nine coordination sites. These
complexes such as Gd-DTPA (linear, Magnevist) and Gd-DO3A-
butrol (macrocyclic, Gadovist) can be applied in vivo and clinically.
However attention has to be paid when Gd-contrast agents are
administered in patients with renal dysfunction. Especially linear
chelate complexes with lower stability may  gradually release free
Gd3+ ions leading to severe forms of nephrogenic systemic ﬁbrosis
[121–125].
Already in 1983, Gd-chelates were applied to detect abdomi-
nal zones of inﬂammation. It was  postulated that Gd-complexes
diffuse readily into the extravascular compartment and enhance
zones of edema formation. These zones feature a high portion
of interstitial ﬂuid and normally show low signal intensities in
T1 weighted images [126]. The uncommon application of T1 con-
trast enhancement in the imaging of abdominal infections has
limited development of this technique. More recently, the appli-
cation of Gd-complexes has become a well established technique
for assessing cerebral infection and the loss of blood–brain-
barrier integrity (Fig. 4). Only in zones of inﬂammation are
Gd-complexes able to pass the vessel wall, which leads to enhanced
T1 relaxation in the surrounding tissue [47,48,127–129]. Dynamic
contrast-enhanced T1 weighted imaging can also be used to
obtain physiological information about perfusion, complementing
anatomic data [130]. For quantiﬁcation of fractional blood volume
and endothelial permeability in zones of inﬂammation, speciﬁc
long-circulating blood-pool contrast agents such as albumin con-
jugated Gd-DTPA were developed, showing a plasma-half life time
of approximately 3 h [131,132].
As with iron oxide particles, Gd-complexes are often bio-
conjugated to speciﬁc antibodies to target immunological or
inﬂammatory processes. For example the ICAM-1 antibody binds
speciﬁcally to ICAM-1-expressing cells. By conjugating the Gd-
DTPA complex with the ICAM-1 antibody, T1 imaging allowed
investigation of inﬂammatory tissue resulting from a S. aureus
infection in the mouse thigh muscle [133]. ICAM-1 is one of the
various adhesion molecules and is highly expressed in activated
leukocytes and inﬁltrating macrophages, which are recognized
by the anti-ICAM-1 antibody. In another study, macromolecular
V. Hoerr, C. Faber / Journal of Pharmaceutical and Biomedical Analysis 93 (2014) 136–146 141
Fig. 3. Detection of iron-labeled macrophages and iron-labeled bacteria. MR images of a subcutaneous S. aureus infection at 24 h post infection. (A) Axial T2*-weighted FLASH
MRI  of a subcutaneous infection induced with unlabeled bacteria, following intravenous co-injection of 5-nm SPIOs 2 h and 5 h post infection. SPIOs were phagocytozed by
macrophages and were detected as signal voids (yellow arrow heads) at the zone of infection (yellow ellipsoid). (B) Axial T2*-weighted FLASH images of the mouse ﬂank,
revealing an ulcerous abscess (yellow ellipsoid) with bacterial colonization (yellow arrow) when iron-labeled bacteria were used to induce the infection. Images were acquired
o 6 ms,  T
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on  a 9.4 T Biospec 94/20 small animal scanner with the following parameters (TE: 
atrix  size: 256 × 256, number of averages: 2). (For interpretation of the reference
adolinium-based G4 dendrimers have been developed as
iomarker for early detection of sepsis-induced acute renal failure,
sing a dynamic T1 weighted fast spoiled gradient echo sequence.
urther, investigations showed that dendrimer-enhanced MRI  is
lso able to provide information about prognosis, and is a valuable
ool to follow therapeutic treatment [134].
In the work of Wei  et al., encephalitis lesions of T. gondii were
nvestigated both by iron contrast and Gd-enhancement [135].
he two contrast-enhanced imaging techniques produced some
omplementary results, and together provided a more detailed
escription about the inﬂammatory status and blood–brain barrier
mpairment. Both the different MRI  methods to detect T1, T2 and
ig. 4. Cerebral lesions enhanced by Gd-contrast. Sagittal T1-weighted FLASH images o
re  and (B) post Gd-administration. In pre-contrast images, inﬂammatory lesions were n
ontrast. After Gd administration, inﬂammatory lesions with impaired blood–brain-barrie
ere  acquired on a 9.4 T Biospec 94/20 small animal scanner with the following param
.5  cm × 1.5 cm,  matrix size: 128 × 128, number of averages: 2). (For interpretation of the
f  this article.)R: 1500 ms,  ﬂip angle: 30◦ , slice thickness: 0.5 mm, ﬁeld of view: 3.2 cm × 3.2 cm,
lor in this ﬁgure legend, the reader is referred to the web version of this article.)
T2* contrast as well as the different molecular properties of iron
particles and Gd-complexes may contribute to the observed differ-
ences, and may  be used to provide a differential diagnosis about
the stage of infection.
7. 19F imaging
Historically, after the introduction of proton MRI, researchers
investigated other nuclei such as 13C, 14N, 17O, 19F, 23Na, 31P. How-
ever, the use of most nuclei is limited by a lack of sensitivity, low
natural abundance, and poor biological concentration. The excep-
tion was 19F imaging, which, by the end of the 1970s emerged as
f the brain of an EAE (experimental autoimmune encephalomyelitis) mouse (A)
ot detected. The lateral ventricle (yellow arrow head) appeared hypointense pre-
r were detected as hyperintensities, in the caudate putamen (yellow arrow). Images
eters (TE: 2.6 ms,  TR: 30 ms, ﬂip angle: 30◦ , slice thickness: 0.5 mm,  ﬁeld of view:
 references to color in this ﬁgure legend, the reader is referred to the web  version
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Fig. 5. 19F MRI  of a murine S. aureus thigh infection at day 3 post infection. 12 h post PFC (perﬂuorcarbon) administration, PFC phagocytozed by macrophages was detected
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ot  the site of infection and allowed for assessment of antibiotic treatment. 19F SSFP
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eprinted with permission from reference [166].
 promising tool and later showed value in molecular and cellular
RI  [136–139]. 19F is a spin-½ isotope with a 100% natural abun-
ance. Its sensitivity, mainly deﬁned by the gyromagnetic ratio, is
3% of that of the 1H nucleus and thus affords a strong MR sig-
al [77,140]. Its gyromagnetic ratio differs only 6% from that of a
roton (25.16 × 107 rad s−1 T−1) and most MR  systems (operating
t low magnetic ﬁelds) can use the proton channel to detect the
uorine resonance frequency [77,137]. The main advantage of 19F
maging is the possibility to unambiguously detect administered
uorine labels. A background signal is not observed, since most tis-
ue contains less than 10−3mol  ﬂuorine per gram wet  tissue, a
oncentration far below the detection limit of current equipment.
he higher ﬂuorine concentration in bones and teeth does not con-
ribute to the MR  signal in conventional MR  methods due to the
ery short transversal relaxation time of the immobilized nuclei
141,142].
For in vivo studies marker substances are mainly perﬂuo-
ocarbons (PFC) with a high density of 19F nuclei. Examples
nclude perﬂuoro-15-crown-5-ether, perﬂuoropolyethylenoxide,
nd perﬂuorooctylbromide. Almost all hydrogens in the organic
ompounds are replaced by ﬂuorine, allowing an image quality
pproaching that of low resolution 1H MRI  [77]. Since, the high
egree of ﬂuorination makes the compounds both very lipopho-
ic and hydrophobic, PFCs are commonly prepared and applied
n emulsions [143]. However PFC can also be linked to dyes
nd quantum dots or can be processed to particles or micelles
142,144]. Compared to other ﬂuorinated compounds whose appli-
ation is limited by their cytotoxicity, PFCs are well studied as blood
ubstitutes, and are inert with a very good biocompatibility. They
re mainly cleared from the body by phagocytosis, exhalation, or
y bowel excretion [77,145,146], and their long biological half-time
from hours to years) makes them suitable for long-term cellular
racking.
Usually the markers are detected and quantiﬁed in vivo directly
y 19F MRI  since the signal is directly proportional to the number
9F nuclei [147]. Interestingly, ﬂuorinated compounds may  also be
tilized as in vivo sensors [148,149], since these compounds can
e sensitive to pH, oxygen concentration, and the concentration of
any ions (e.g. Na+, Ca2+ and Mg2+). A main limitation of 19F MRI
s the SNR obtained. Even though the sensitivity of the 19F nucleus
s high, the concentration of the ﬂuorinated probes at the site of
nfection is often low, requiring acquisitions with optimized SNR
fﬁciency (SNR/
√
t). Commonly used fast acquisition sequences
re usually based on fast low angle shot (FLASH) gradient echo
equences [150–152] or rapid acquisition with relaxation enhance-
ent (RARE)/ultra-fast-low-angle-(RARE) fast spin echo sequences
153,154]. To achieve T1 weighted images these sequences are
ften combined with an inversion recovery pulse sequence [152].ages of the infected thigh muscle treated with (A) 0.9% NaCl, (B) Vancomycin and
Especially when 19F imaging is applied to determine oxygen
dynamics, ultra-fast imaging techniques such as echo planar imag-
ing (EPI) are also applied [155–157]. Another reason for the low
SNR in 19F MRI  is the long T1 relaxation time of most of the ﬂuori-
nated compounds, which can last longer than 4 s and thus requires
long repetition and acquisition times [158]. To overcome this
unfavorable characteristic, Gd-chelates can be applied as ﬂuorine
relaxation agents, which however affect both T1 and T2 relaxation
[158], making ultrafast sequences such as UTE or zero-echo-time
(ZTE) necessary [159]. In recent years, several novel acceleration
approaches such as compressed sensing algorithms [160] and par-
allel imaging techniques, have been introduced, which might offer
novel options for improving the SNR efﬁciency in 19F MRI  in the
near future. Currently, it appears the limitations of 19F imaging have
outweighed its advantageous properties, and the application of 19F
imaging to infectious disease studies has been limited. In 1985,
the ﬁrst successful in vivo infection study utilized the exogenous
ﬂuorine agent perﬂuorotributylamine (PFTA) to track endogenous
macrophages in intraperitoneal bacterial abscesses in rats [161].
However, few investigations have followed, with only a few19F MRI
studies of sterile inﬂammation being reported [162–164]. Recently,
Hertlein et al. [165] investigated macrophage trafﬁcking in mouse
model of S. aureus infection by using both PFC emulsions and SPIOs.
Comparison of the two methods found strong PFC accumulation at
the rim of the bacterial abscess in the thigh muscle, both in the acute
and chronic phase of the infection which allowed for the assess-
ment of antibiotic treatment by 19F MRI  (Fig. 5) [166]. By contrast,
only diffuse and unclear susceptibility effects were detected at the
site of the chronic infection when SPIOs were administered.
8. Novel approaches and challenges
Most microbes can infect a number of different organs that
all have tissue-speciﬁc magnetic properties and, therefore, may
require more than one MR  imaging approach combining, e.g.
diffusion-weighted imaging, perfusion imaging, and MR angiogra-
phy. Additional information about the most important metabolic
changes in the zone of inﬂammation may  be obtained by in vivo
magnetic resonance spectroscopy (MRS). Especially 31P MRS  is
a powerful tool to provide detailed insight into tissue bioen-
ergetics and phospholipid metabolism. While there are several
studies demonstrating the useful adjunct of MR  spectra in the
diagnosis of brain infections using single voxel techniques such as
PRESS (point-resolved spectroscopy) [167,168] or STEAM (stimu-
lated echo acquisition mode) [169,170], their application to mouse
models of infection is quite limited [171,73]. The possibility of
using hyperpolarized nuclei such as 13C, 15N and 31P further
prompted the research ﬁelds of MRI  and MRS, but has not yet been
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pplied to infectious diseases [172–176]. Even though the techni-
al feasibility of studying infectious diseases by MRI  and MRS  has
eveloped tremendously, it has become obvious that other analyt-
cal techniques have to be combined with MRI  to obtain a profound
nderstanding of disease. In systemic microbial infections, such as
. aureus infections, a whole-organism inﬂammatory response is
nduced. Cellular and cytokine analytical techniques are required to
btain information about the immune factors that are either acti-
ated by the infection or are causative of the infection. Many of
hese techniques are applied to homogenized tissue or extracts and
mply the loss of anatomical information. In recent years, the focus
or studying disease mechanisms and ﬁnding novel diagnostic tools
as progressed from single disease-speciﬁc markers to bioproﬁles.
hese approaches comprise well-deﬁned sets of reliable molecu-
ar indicators [177,178] using platforms such as proteomics [179],
ranscriptomics [180] genomics [178] and metabolomics [181].
he “omics” technologies are based on systematic data analysis of
arge datasets of genes, proteins and low molecular mass metabo-
ites using multivariate pattern recognition techniques. Especially
roteomics and metabolomics became useful tools to study infec-
ious diseases, since the proteomic and metabolic patterns change
uickly with cellular conditions [182,183]. Metabolomics charac-
erizes and quantiﬁes a plethora of metabolites from bioﬂuids such
s urine, serum and cerebrospinal ﬂuid, using mass spectrometry or
igh resolution NMR  spectroscopy. In proteomics a direct measure
f the present protein composition and quantity can be obtained by
LISA and mass spectrometry. Thus, the “omics” technologies may
rovide supplemental data that add to the information obtained
ith pure imaging approaches, which have been established as
tate of the art over the recent years. Future studies and diagnos-
ic tools will most likely rely on a combination of in vivo imaging
ith methods from the “omics” toolbox. A further major step in
echnological development may  be the implementation of MRI
ngerprinting [184] in these diagnostic tools. MRI ﬁngerprinting
ccelerates data acquisition by more than one order of magni-
ude by sampling parameter space instead of the full reciprocal
mage space. Using this novel technology MRI  may  become a real
igh-throughput method in microbiological diagnosis and investi-
ations.
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